| __timestamp | PTC Therapeutics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 91733000 |
| Thursday, January 1, 2015 | 82080000 | 87644000 |
| Friday, January 1, 2016 | 97130000 | 92365000 |
| Sunday, January 1, 2017 | 121271000 | 85656000 |
| Monday, January 1, 2018 | 153548000 | 88196000 |
| Tuesday, January 1, 2019 | 202541000 | 89971000 |
| Wednesday, January 1, 2020 | 245164000 | 93413000 |
| Friday, January 1, 2021 | 285773000 | 91355000 |
| Saturday, January 1, 2022 | 325998000 | 113676000 |
| Sunday, January 1, 2023 | 332540000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of PTC Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, PTC Therapeutics has seen a staggering increase in SG&A expenses, growing by over 640%, from approximately $44.8 million to $332.5 million. In contrast, Taro Pharmaceutical's expenses have shown a more modest increase of about 116%, from $91.7 million to $198.4 million. Notably, Taro's expenses remained relatively stable until a significant rise in 2023. This divergence highlights PTC's aggressive expansion strategy, while Taro maintains a more conservative approach. Missing data for 2024 suggests a need for further updates to capture the latest trends. These insights provide a window into the strategic priorities of these pharmaceutical leaders.
United Therapeutics Corporation or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Insmed Incorporated vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Catalent, Inc. and Taro Pharmaceutical Industries Ltd.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Taro Pharmaceutical Industries Ltd.
Alkermes plc or PTC Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or Celldex Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?